Request for Covid-19 Impact Assessment of this Report
The growth of the PACS and RIS market is primarily attributed to the affordable price of new generation PACS software and rising prevalence of dental diseases. However, concerns regarding data privacy is likely to pose a negative impact on the market growth. On the other hand, increasing demand for orthopaedic PACS is likely to have a positive impact on the growth of the North America PACS and RIS market in the coming years.
Tooth loss is one of the sensitive indicator of access to dental care and overall dental health. In a broad perspective, the prevalence of both partial and total tooth loss in adults and seniors has decreased since the early 1970s, according to a study by National Health Services. In spite of these improvement, significant disparities remain in some population groups related to tooth loss and insufficient dental care. As per the World health Organization’s, Global Burden of Disease Study 2016 estimated that around 3.58 billion people across the globe suffer from dental caries (tooth decay) in permanent teeth. The WHO also states that periodontal (gum) disease, which is a prominent cause of tooth loss was estimated to be the 11th most prevalent disease on a global scale. According to the American College of Prosthodontists (ACP), 178 million Americans are missing at least one tooth. Additionally, an average of 40 million people in the US are missing all of their teeth. The ACP estimates that this number is expected to rise over the next two decades owing to increasing cavity and tooth decay. According to a Brazilian study published in the International Journal of Dentistry, the major reasons responsible for dental implant procedures in Brazil were, Cavities (38.4%), periodontal diseases (32.2%), eruption problems (6.4%), orthodontics (5.7%), prosthetics (3.6%), injury/trauma (2.6%), occlusal problems (1.1%), and others (9%). Furthermore, American Dental Association (ADA) statistics 2015, ninety-one percent of Americans over the age of 20 years have suffered from dental cavities at least once in their lives. The high prevalence of dental issues will boost the adoption of PACS and RIS in the coming few years.
In 2018, the Picture Archive and Communication System (PACS) segment held the most significant market share of the PACS and RIS market, by product. This segment is also anticipated to dominate the market in 2027 as the solution offers benefits such as improved viewing and analysis, easy access to images and other reports, efficient data management as well as a user-friendly interface. Also, the segment is anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027.
In 2018, the software segment held a most significant market share of the PACS and RIS market, by component. This segment is also estimated to dominate the market in 2027 since software form an integral part of PACS and RIS. Software used in PACS and RIS is a central-server solution that offers all clinics and departments assistance during procedures. Also, the segment is also anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027.
In 2018, the web-based segment held the most significant market share of the PACS and RIS market, by deployment. This segment is also projected to dominate the market in 2027 due to benefits such as enhanced service for physicians as well as improved patient care. However, the cloud-based segment is anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027, due to the increased adoption as well as the development of cloud-based solutions.
In 2018, the hospitals segment held a considerable market share of the PACS and RIS market, by end user. This segment is also predicted to dominate the market in 2027 owing to the availability of better healthcare facilities as well as the presence of reimbursement policies that lead to growth in the number of procedures conducted. Also, the segment is anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027.
Some of the major primary and secondary sources for PACS and RIS included in the report are, The American Dental Association (ADA), The American Heart Association (AHA), Business Monitor International (BMI), The Canadian Association of Radiologists (CAR), The Food and Drug Administration (FDA) and others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. North America PACS and RIS Market - Key Takeaways
3. North America PACS and RIS Market - Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 North America PACS and RIS Market - By Product
3.2.2 North America PACS and RIS Market - By Component
3.2.3 North America PACS and RIS Market - By Deployment
3.2.4 North America PACS and RIS Market - By End User
3.2.5 North America PACS and RIS Market - By Country
3.3 PEST Analysis
4. North America PACS and RIS Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Affordable Price of New Generation PACS Software
4.1.2 Rising Prevalence of Dental Diseases
4.2 Key Market Restraints
4.2.1 Concerns Regarding Data Privacy
4.3 Key Market Opportunities
4.3.1 Increasing Demand for Orthopaedic PACS
4.4 Trend
4.4.1 Continuous Technological Advancements
4.5 Impact Analysis
5. PACS and RIS Market - North America Analysis
5.1 North America PACS and RIS Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Company Share By Geography (2018)
6. North America PACS and RIS Market Analysis - By Product
6.1 Overview
6.2 North America PACS and RIS Market By Product, 2018 & 2027 (%)
6.3 North America PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
6.4 Picture Archive and Communication System (PACS) Market
6.4.1 Overview
6.4.2 North America Picture Archive and Communication System (PACS) Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Radiology Information System (RIS) Market
6.5.1 Overview
6.5.2 North America Radiology Information System (RIS) Market Revenue and Forecasts to 2027 (US$ Mn)
7. North America PACS and RIS Market Analysis - By Component
7.1 Overview
7.2 North America PACS and RIS Market, By Component, 2018 & 2027 (%)
7.3 North America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
7.4 Software Market
7.4.1 Overview
7.4.2 North America Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Hardware Market
7.5.1 Overview
7.5.2 North America Hardware Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Services Market
7.6.1 Overview
7.6.2 North America Services Market Revenue and Forecasts to 2027 (US$ Mn)
8. Global PACS and RIS Market Analysis- by Deployment
8.1 Overview
8.2 North America PACS and RIS Market, By Deployment 2018 & 2027 (%)
8.3 North America PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
8.4 Web-Based Market
8.4.1 Overview
8.4.2 North America Web-Based Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 On-Premise Market
8.5.1 Overview
8.5.2 North America On-Premise Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Cloud-Based Market
8.6.1 Overview
8.6.2 North America Cloud-Based Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America PACS and RIS Market Analysis- by End User
9.1 Overview
9.2 North America PACS and RIS Market, By End User 2018 & 2027 (%)
9.3 North America PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 Hospitals Market
9.4.1 Overview
9.4.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Diagnostic Centers Market
9.5.1 Overview
9.5.2 North America Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others Market
9.6.1 Overview
9.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. North America PACS and RIS Market Revenue and Forecasts To 2027
10.1 Overview
10.2 North America PACS and RIS Market Revenue And Forecasts to 2027 (US$ Mn)
10.3 North America PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4 North America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
10.5 North America PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
10.6 North America PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.7 North America PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)
10.7.1 US PACS and RIS Market Revenue and Forecasts To 2027 (US$ Mn)
10.7.1.1 US PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.1.2 US PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.1.3 US America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
10.7.1.4 US PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
10.7.1.5 US PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.7.2 Canada PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.2.1 Canada PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.2.2 Canada PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.2.3 Canada PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
10.7.2.4 Canada PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
10.7.2.5 Canada PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.7.3 Mexico PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.3.1 Mexico PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.3.2 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.3.3 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
10.7.3.4 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
10.7.3.5 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. PACS and RIS Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies In The PACS and RIS Market, 2016-2019
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies in the PACS and RIS Market, 2016-2019 (%)
11.4.1 Collaborations
11.4.1.1 Recent Collaborations By Players In The PACS and RIS Market
11.4.2 Agreements, Partnerships and Joint Ventures
11.4.2.1 Recent Agreements, Partnerships And Joint Ventures By Players In The PACS and RIS Market
11.4.3 Acquisitions
11.4.3.1 Recent Acquisitions By Players In The PACS and RIS Market
11.5 Organic Growth Strategies
11.5.1 Overview
11.6 Organic Growth Strategies in the PACS and RIS Market, 2016-2019 (%)
11.6.1 Product Launches
11.6.1.1 Recent Product Launches By Players In The PACS and RIS Market
11.6.2 Product Approval & Other Organic Growth Strategies
11.6.2.1 Recent Product Approval & Other Organic Growth Strategies By Players In The PACS and RIS Market
12. PACS and RIS Market-Key Company Profiles
12.1 Agfa-Gevaert Group
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 INFINITT Healthcare Co., Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 McKesson Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cerner Corporation
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 General Electric Company
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips N.V.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 FUJIFILM Holdings Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Siemens AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 IBM
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Novarad
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary Of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
Table 1. North America PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 2. North America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
Table 3. North America PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
Table 4. North America PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 5. North America PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 6. North America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
Table 7. North America PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
Table 8. North America PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 9. US PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 10. US PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
Table 11. US PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
Table 12. US PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 13. Canada PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 14. Canada PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
Table 15. Canada PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
Table 16. Canada PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 17. Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 18. Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
Table 19. Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
Table 20. Mexico PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 21. Recent Collaborations By Players In The PACS and RIS Market
Table 22. Recent Agreements, Partnerships And Joint Ventures By Players In The PACS and RIS Market
Table 23. Recent Acquisitions By Players In The PACS and RIS Market
Table 24. Recent Product Launches in the PACS and RIS Market
Table 25. Recent Product Approval & Other Organic Growth Strategies in the PACS and RIS Market
Table 26. Glossary Of Terms, PACS and RIS Market
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...